{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:12:12Z","timestamp":1788941532930,"version":"build-2803163510"},"reference-count":171,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.pharmthera.2012.05.003","type":"journal-article","created":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T17:16:39Z","timestamp":1340385399000},"page":"151-167","source":"Crossref","is-referenced-by-count":68,"title":["The glycine deportation system and its pharmacological consequences"],"prefix":"10.1016","volume":"135","author":[{"given":"Diren","family":"Beyo\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Idle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2012.05.003_bb0005","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/clpt.1986.144","article-title":"The effect of aspirin on valproic acid metabolism","volume":"40","author":"Abbott","year":"1986","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0010","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1042\/bj1160437","article-title":"Species differences in the aromatization of quinic acid in vivo and the role of gut bacteria","volume":"116","author":"Adamson","year":"1970","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0015","first-page":"2519","article-title":"Isophosphamide as a new acrolein-producing antineoplastic isomer of cyclophosphamide","volume":"32","author":"Alarcon","year":"1972","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0020","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0003-9861(55)90070-9","article-title":"Influence of nicotinic acid on serum cholesterol in man","volume":"54","author":"Altschul","year":"1955","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0025","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/pbc.22361","article-title":"Ifosfamide-induced encephalopathy and movement disorder","volume":"54","author":"Ames","year":"2010","journal-title":"Pediatric Blood & Cancer"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/jps.2600580307","article-title":"Drug biotransformation interactions in man. II. A pharmacokinetic study of the simultaneous conjugation of benzoic and salicylic acids with glycine","volume":"58","author":"Amsel","year":"1969","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0035","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/ajmg.a.31030","article-title":"Glycine encephalopathy (nonketotic hyperglycinemia): comments and speculations","volume":"140","author":"Applegarth","year":"2006","journal-title":"American Journal of Medical Genetics. Part A"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0040","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/181931a0","article-title":"Chemotherapeutic action of a cyclic nitrogen mustard phosphamide ester (B 518-ASTA) in experimental tumours of the rat","volume":"181","author":"Arnold","year":"1958","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0045","first-page":"143","article-title":"On the relation between the chemical composition and the cancerotoxic effect in a series of phosphamide esters of bis-(beta-chloroethyl)-a mine","volume":"11","author":"Arnold","year":"1961","journal-title":"Arzneimittel-Forschung"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0050","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1042\/bj0500154","article-title":"Hippuric acid synthesis in the rat","volume":"50","author":"Arnstein","year":"1951","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0055","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/213726a0","article-title":"Glyoxylate as a substrate for lactate dehydrogenase","volume":"213","author":"Banner","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0060","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(80)80416-1","article-title":"Treatment of hyperammonemic coma caused by inborn errors of urea synthesis","volume":"97","author":"Batshaw","year":"1980","journal-title":"The Journal of Pediatrics"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0065","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02263659","article-title":"Evidence of lack of toxicity of sodium phenylacetate and sodium benzoate in treating urea cycle enzymopathies","volume":"4","author":"Batshaw","year":"1981","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0006-8993(71)90419-7","article-title":"The uptake of various amino acids by the mouse brain in vivo","volume":"29","author":"Battistin","year":"1971","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0075","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/0005-2736(80)90038-3","article-title":"Glycine transport in rat brain and liver mitochondria","volume":"598","author":"Benavides","year":"1980","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1042\/BST0340055","article-title":"Glycine transporters: essential regulators of synaptic transmission","volume":"34","author":"Betz","year":"2006","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0085","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/j.1471-4159.2006.03908.x","article-title":"Glycine receptors: recent insights into their structural organization and functional diversity","volume":"97","author":"Betz","year":"2006","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0090","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.bcp.2011.12.031","article-title":"Dog bites man or man bites dog? The enigma of the amino acid conjugations","volume":"83","author":"Beyo\u011flu","year":"2011","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0095","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0021-9258(18)85489-8","article-title":"Studies on urinary acidity. II. The increased acidity produced by eating prunes and cranberries","volume":"57","author":"Blatherwick","year":"1923","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0021-9258(19)51300-X","article-title":"An estimation of acetic acid formation in the rat","volume":"159","author":"Bloch","year":"1945","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0959-8049(94)00300-T","article-title":"Pharmacokinetics, metabolism and clinical effect of ifosfamide in breast cancer patients","volume":"31A","author":"Boddy","year":"1995","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2011.11.090","article-title":"Pre-clinical characterization of [(11)C]R05013853 as a novel radiotracer for imaging of the glycine transporter type 1 by positron emission tomography","author":"Borroni","year":"2011","journal-title":"NeuroImage"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0115","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1042\/bj0630507","article-title":"Species differences in the conjugation of free bile acids with taurine and glycine","volume":"63","author":"Bremer","year":"1956","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0120","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3891\/acta.chem.scand.09-0689","article-title":"Studies on the conjugation of cholic acid with taurine in cell subfractions. Bile acids and steroids 23","volume":"9","author":"Bremer","year":"1955","journal-title":"Acta Chemica Scandinavica"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0125","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF01810858","article-title":"Comet Halley as an aggregate of interstellar dust and further evidence for the photochemical formation of organics in the interstellar medium","volume":"22","author":"Briggs","year":"1992","journal-title":"Origins of Life and Evolution of the Biosphere"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0130","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/1097-0142(1967)20:5<900::AID-CNCR2820200552>3.0.CO;2-Y","article-title":"Metabolism of cyclophosphamide","volume":"20","author":"Brock","year":"1967","journal-title":"Cancer"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF00410691","article-title":"Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds","volume":"100","author":"Brock","year":"1981","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0140","first-page":"659","article-title":"Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide","volume":"29","author":"Brock","year":"1979","journal-title":"Arzneimittel-Forschung"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0145","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJM198406213102503","article-title":"Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis","volume":"310","author":"Brusilow","year":"1984","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0150","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0140-6736(79)91503-4","article-title":"New pathways of nitrogen excretion in inborn errors of urea synthesis","volume":"2","author":"Brusilow","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0155","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10482-008-9269-4","article-title":"The detection of hipO gene by real-time PCR in thermophilic Campylobacter spp. with very weak and negative reaction of hippurate hydrolysis","volume":"94","author":"Caner","year":"2008","journal-title":"Antonie Van Leeuwenhoek"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0160","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(85)91288-7","article-title":"Ifosfamide\/mesa and encephalopathy","volume":"1","author":"Cantwell","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0165","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0022-3565(24)29242-9","article-title":"Insights into the mechanisms of ifosfamide encephalopathy: drug metabolites have agonistic effects on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)\/kainate receptors and induce cellular acidification in mouse cortical neurons","volume":"299","author":"Chatton","year":"2001","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0170","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1021\/ac971294i","article-title":"Measuring DNA synthesis rates with [1-13C]glycine","volume":"70","author":"Chen","year":"1998","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0175","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/mrm.22857","article-title":"Measurement of glycine in the human brain in vivo by 1H-MRS at 3 T: application in brain tumors","volume":"66","author":"Choi","year":"2011","journal-title":"Magnetic Resonance in Medicine"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0180","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3181\/00379727-104-25860","article-title":"Role of intestinal bacteria in aromatization of quinic acid in man and guinea pig","volume":"104","author":"Cotran","year":"1960","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/nrendo.2012.22","article-title":"Niacin: another look at an underutilized lipid-lowering medication","author":"Creider","year":"2012","journal-title":"Nature Reviews. Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0190","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0021-9258(18)85186-9","article-title":"On the administration of various proteins with benzoic acid to a pig","volume":"60","author":"Csonka","year":"1924","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0195","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/cercor\/bhh147","article-title":"Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain","volume":"15","author":"Cubelos","year":"2005","journal-title":"Cerebral Cortex"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0205","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/0929867305666220314214937","article-title":"The glycine site on the NMDA receptor: structure\u2013activity relationships and possible therapeutic applications","volume":"5","author":"Dannhardt","year":"1998","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0210","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1172\/JCI102014","article-title":"Studies on amino acid metabolism. III. Plasma glycine concentration and hippuric acid formation following the ingestion of benzoate","volume":"27","author":"de Vries","year":"1948","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0215","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1124\/jpet.105.085613","article-title":"Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats","volume":"314","author":"Deguchi","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0220","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3181\/00379727-148-38592","article-title":"The effect of sodium benzoate and taurocholic acid feeding on human bile composition","volume":"148","author":"Dennis","year":"1975","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0225","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1177\/0883073811402204","article-title":"Valproate-induced worsening of seizures: clue to underlying diagnosis","volume":"26","author":"Dhamija","year":"2011","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0230","first-page":"CS22","article-title":"Neurotoxicity during ifosfamide treatment in children","volume":"15","author":"Di Cataldo","year":"2009","journal-title":"Medical Science Monitor"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0235","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/clpt.1989.200","article-title":"Pharmacokinetics of nicotinic acid-salicylic acid interaction","volume":"46","author":"Ding","year":"1989","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0240","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1360-1385(01)01892-1","article-title":"The glycine decarboxylase system: a fascinating complex","volume":"6","author":"Douce","year":"2001","journal-title":"Trends in Plant Science"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0245","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/BF01471475","article-title":"Specific chemotherapy of carcinoma of the prostate","volume":"30","author":"Druckrey","year":"1952","journal-title":"Klinische Wochenschrift"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0200","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0006-3223(99)00133-X","article-title":"IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans","volume":"47","author":"D'Souza","year":"2000","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0250","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1515\/znc-1975-7-808","article-title":"Reaction of glutathione with conjugated carbonyls","volume":"30","author":"Esterbauer","year":"1975","journal-title":"Zeitschrift f\u00fcr Naturforschung. C, Journal of Biosciences"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0255","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/jn\/6.5.455","article-title":"Effect of cranberries on urinary acidity and blood alkali reserve","volume":"6","author":"Fellers","year":"1933","journal-title":"The Journal of Nutrition"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0260","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2967\/jnumed.107.049064","article-title":"Synthesis and evaluation of a series of 99mTc(CO)3+ lisinopril complexes for in vivo imaging of angiotensin-converting enzyme expression","volume":"49","author":"Femia","year":"2008","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0265","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0026-895X(25)12659-X","article-title":"Enzymatic conversion of salicylate to salicylurate","volume":"7","author":"Forman","year":"1971","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0270","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/00007691-199608000-00032","article-title":"Nuclear magnetic resonance and high-performance liquid chromatography-nuclear magnetic resonance studies on the toxicity and metabolism of ifosfamide","volume":"18","author":"Foxall","year":"1996","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0275","first-page":"1507","article-title":"Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy","volume":"3","author":"Foxall","year":"1997","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0280","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/bst0040525","article-title":"The localization of hippurate synthesis in the matrix of rat liver mitochondria","volume":"4","author":"Gatley","year":"1976","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0285","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1042\/bj1660039","article-title":"The synthesis of hippurate from benzoate and glycine by rat liver mitochondria. Submitochondrial localization and kinetics","volume":"166","author":"Gatley","year":"1977","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0290","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0022-3565(24)37995-9","article-title":"Differences in excretion of hippurate, as a metabolite of benzoate and as an administered species, in the single-pass isolated perfused rat kidney explained","volume":"288","author":"Geng","year":"1999","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0295","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nchem.827","article-title":"Synthesis of glycine-containing complexes in impacts of comets on early Earth","volume":"2","author":"Goldman","year":"2010","journal-title":"Nature Chemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0300","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/jn\/133.6.1853","article-title":"Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats","volume":"133","author":"Gonthier","year":"2003","journal-title":"The Journal of Nutrition"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0305","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1016\/0006-2952(94)90268-2","article-title":"Gut flora and the origin of some urinary aromatic phenolic compounds","volume":"47","author":"Goodwin","year":"1994","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0310","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1124\/dmd.31.1.114","article-title":"Amino acid conjugates: metabolites of 2-propylpentanoic acid (valproic acid) in epileptic patients","volume":"31","author":"Gopaul","year":"2003","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0315","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(86)92227-0","article-title":"Dechloroethylation of ifosfamide and neurotoxicity","volume":"2","author":"Goren","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0320","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1471-4159.2003.01972.x","article-title":"Blood-mediated scavenging of cerebrospinal fluid glutamate","volume":"87","author":"Gottlieb","year":"2003","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0325","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0090-9556(25)08473-9","article-title":"Does hepatic ATP depletion impair glycine conjugation in vivo?","volume":"24","author":"Gregus","year":"1996","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0330","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/00498259309059370","article-title":"Dependence of glycine conjugation on availability of glycine: role of the glycine cleavage system","volume":"23","author":"Gregus","year":"1993","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0335","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0022-3565(25)39483-8","article-title":"Effect of valproic acid on glycine conjugation of benzoic acid","volume":"267","author":"Gregus","year":"1993","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0340","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0021-9258(18)84778-0","article-title":"Benzoylated amino acids in the animal organism. I. The behavior of hippuric acid following its oral administration","volume":"66","author":"Griffith","year":"1925","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9258(18)85523-5","article-title":"Studies in the synthesis of hippuric acid in the animal organism. V. The influence of amino acids and related substances on the synthesis and rate of elimination of hippuric acid after the administration of benzoate","volume":"57","author":"Griffith","year":"1923","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0350","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/mds.10681","article-title":"Adult nonketotic hyperglycinemia (NKH) crisis presenting as severe chorea and encephalopathy","volume":"19","author":"Hall","year":"2004","journal-title":"Movement Disorders"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0355","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0022-3476(05)82559-4","article-title":"Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant","volume":"121","author":"Hamosh","year":"1992","journal-title":"The Journal of Pediatrics"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0360","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/S0021-9258(18)32819-9","article-title":"Regulation of the glycine cleavage system in isolated rat liver mitochondria","volume":"258","author":"Hampson","year":"1983","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0365","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0021-9258(17)43585-X","article-title":"Regulation of the glycine cleavage system in the isolated perfused rat liver","volume":"259","author":"Hampson","year":"1984","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0370","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jn\/71.2.159","article-title":"Biosynthesis of sterols and fatty acids as affected by nicotinic acid and related compounds","volume":"71","author":"Hardy","year":"1960","journal-title":"The Journal of Nutrition"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0375","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1042\/bj0570126","article-title":"Comparative studies of bile salts. 8. Preliminary examination of bile salts by paper chromatography","volume":"57","author":"Haslewood","year":"1954","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0380","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1432-1033.1985.tb09260.x","article-title":"Mitochondrial aldehyde dehydrogenase from human liver. Primary structure, differences in relation to the cytosolic enzyme, and functional correlations","volume":"153","author":"Hempel","year":"1985","journal-title":"European Journal of Biochemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0385","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1113\/jphysiol.2004.067801","article-title":"Bergmann glial GlyT1 mediates glycine uptake and release in mouse cerebellar slices","volume":"560","author":"Huang","year":"2004","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0390","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1620\/tjem.126.133","article-title":"Changes in free amino acids of cerebrospinal fluid and plasma in various neurological diseases","volume":"126","author":"Iijima","year":"1978","journal-title":"The Tohoku Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0395","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1479-8425.2006.00193.x","article-title":"Subjective effects of glycine ingestion before bedtime on sleep quality","volume":"4","author":"Inagawa","year":"2006","journal-title":"Sleep and Biological Rhythms"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0400","series-title":"Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline","author":"IOM","year":"1998"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0405","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF03401940","article-title":"Exclusion of angiotensin I-converting enzyme as a candidate gene involved in exudative inflammatory resistance in F344\/N rats","volume":"6","author":"Jafarian-Tehrani","year":"2000","journal-title":"Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0410","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1167\/iovs.06-0248","article-title":"Acrolein, a toxicant in cigarette smoke, causes oxidative damage and mitochondrial dysfunction in RPE cells: protection by (R)-alpha-lipoic acid","volume":"48","author":"Jia","year":"2007","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0415","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0021-9258(19)40004-5","article-title":"Stimulation of glycine catabolism in isolated perfused rat liver by calcium mobilizing hormones and in isolated rat liver mitochondria by submicromolar concentrations of calcium","volume":"265","author":"Jois","year":"1990","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0420","doi-asserted-by":"crossref","first-page":"35073","DOI":"10.1074\/jbc.M109.062414","article-title":"Vesicular inhibitory amino acid transporter is a Cl-\/gamma-aminobutyrate co-transporter","volume":"284","author":"Juge","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0425","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00424-003-1146-4","article-title":"The glutamate\/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects","volume":"447","author":"Kanai","year":"2004","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0430","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.pep.2005.11.006","article-title":"Purification, characterization, and mass spectrometric sequencing of a medium chain acyl-CoA synthetase from mouse liver mitochondria and comparisons with the homologues of rat and bovine","volume":"47","author":"Kasuya","year":"2006","journal-title":"Protein Expression and Purification"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0435","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0009-2797(99)00163-5","article-title":"Difference of the liver and kidney in glycine conjugation of ortho-substituted benzoic acids","volume":"125","author":"Kasuya","year":"2000","journal-title":"Chemico-Biological Interactions"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0440","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pscychresns.2009.03.004","article-title":"Oral glycine administration increases brain glycine\/creatine ratios in men: a proton magnetic resonance spectroscopy study","volume":"173","author":"Kaufman","year":"2009","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0445","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jbt.2570080203","article-title":"Isolation and characterization of mitochondrial acyl-CoA: glycine N-acyltransferases from kidney","volume":"8","author":"Kelley","year":"1993","journal-title":"Journal of Biochemical Toxicology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0450","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/pbc.20665","article-title":"Ifosfamide neurotoxicity: an atypical presentation with psychiatric manifestations","volume":"47","author":"Kerdudo","year":"2006","journal-title":"Pediatric Blood & Cancer"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0455","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2183\/pjab.84.246","article-title":"Glycine cleavage system: reaction mechanism, physiological significance, and hyperglycinemia","volume":"84","author":"Kikuchi","year":"2008","journal-title":"Proceedings of the Japan Academy. Series B, Physical and Biological Sciences"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0460","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0003-9861(79)90535-6","article-title":"Reduction of the level of the glycine cleavage system in the rat liver resulting from administration of dipropylacetic acid: an experimental approach to hyperglycinemia","volume":"198","author":"Kochi","year":"1979","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0465","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1006\/geno.1995.1182","article-title":"Cloning, structure, and chromosome localization of the mouse glutaryl-CoA dehydrogenase gene","volume":"28","author":"Koeller","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0470","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ana.20759","article-title":"Treatment from birth of nonketotic hyperglycinemia due to a novel GLDC mutation","volume":"59","author":"Korman","year":"2006","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0475","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/ast.2006.0102","article-title":"Glycine identification in natural jarosites using laser desorption Fourier transform mass spectrometry: implications for the search for life on Mars","volume":"8","author":"Kotler","year":"2008","journal-title":"Astrobiology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0480","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-6264(67)83152-3","article-title":"Physiological and histological changes in rats fed benzoic acid","volume":"5","author":"Kreis","year":"1967","journal-title":"Food and Cosmetics Toxicology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0485","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0140-6736(94)91839-2","article-title":"Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue","volume":"343","author":"K\u00fcpfer","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0490","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s100380170057","article-title":"Chromosomal localization, structure, single-nucleotide polymorphisms, and expression of the human H-protein gene of the glycine cleavage system (GCSH), a candidate gene for nonketotic hyperglycinemia","volume":"46","author":"Kure","year":"2001","journal-title":"Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0495","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1016\/S0021-9258(18)49992-9","article-title":"The glycine cleavage system. The coupled expression of the glycine decarboxylase gene and the H-protein gene in the chicken","volume":"266","author":"Kure","year":"1991","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0500","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3406\/pharm.2003.5479","article-title":"Pharmacist and chemist Henri Braconnot","volume":"51","author":"Labrude","year":"2003","journal-title":"Revue d'Histoire de la Pharmacie"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0505","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/BF00686635","article-title":"Depletion of total cysteine, glutathione, and homocysteine in plasma by ifosfamide\/mesna therapy","volume":"35","author":"Lauterburg","year":"1994","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0510","first-page":"9","article-title":"XXV. Ueber die Reduction der Chinas\u00e4ure zu Benzo\u00ebs\u00e4ure und die Verwandlung derselben in Hippurs\u00e4ure im thierischen Organismus","volume":"125","author":"Lautermann","year":"1863","journal-title":"European Journal of Organic Chemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0515","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/00365590701570953","article-title":"Urological implications of cyclophosphamide and ifosfamide","volume":"42","author":"Lawson","year":"2008","journal-title":"Scandinavian Journal of Urology and Nephrology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0520","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1212\/WNL.49.5_Suppl_4.S66","article-title":"Cerestat and other NMDA antagonists in ischemic stroke","volume":"49","author":"Lees","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0525","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.toxlet.2005.09.002","article-title":"Cerebral formation in situ of S-carboxymethylcysteine after ifosfamide administration to mice: a further clue to the mechanism of ifosfamide encephalopathy","volume":"161","author":"Lerch","year":"2006","journal-title":"Toxicology Letters"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0530","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/jps.2600540703","article-title":"Pharmacokinetics of salicylate elimination in man","volume":"54","author":"Levy","year":"1965","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0535","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.bcp.2010.06.002","article-title":"Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics","volume":"80","author":"Li","year":"2010","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0540","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1128\/JCM.23.1.118-123.1986","article-title":"Two-dimensional thin-layer chromatography for the specific detection of hippurate hydrolysis by microorganisms","volume":"23","author":"Lin","year":"1986","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0545","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/0006-2952(89)90419-X","article-title":"The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivo","volume":"38","author":"Lind","year":"1989","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0550","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF02897254","article-title":"The effect of route of administration and fractionation of dose on the metabolism of ifosfamide","volume":"26","author":"Lind","year":"1990","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0555","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1028-4559(10)60014-9","article-title":"Ifosfamide-induced encephalopathy in patients with uterine sarcoma","volume":"49","author":"Liu","year":"2010","journal-title":"Taiwanese Journal of Obstetrics & Gynecology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0560","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.bcp.2011.07.103","article-title":"Valproic acid utilizes the isoleucine breakdown pathway for its complete beta-oxidation","volume":"82","author":"Luis","year":"2011","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0565","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.schres.2008.02.002","article-title":"Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia","volume":"101","author":"Madeira","year":"2008","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0570","first-page":"142","article-title":"Strychnine\u2013a killer from the past","volume":"10","author":"Makarovsky","year":"2008","journal-title":"The Israel Medical Association Journal"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0575","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1128\/JCM.28.12.2828-2829.1990","article-title":"Detection of hippurate hydrolysis by Legionella spp. by using a rapid high-performance liquid chromatography method","volume":"28","author":"Marmet","year":"1990","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0580","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0022-2275(20)41905-4","article-title":"Use of [15N]glycine in the measurement of apolipoprotein B synthesis in perfused rat liver","volume":"32","author":"Marsh","year":"1991","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0585","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1136\/jnnp.2010.229104","article-title":"Antiglycine-receptor encephalomyelitis with rigidity","volume":"82","author":"Mas","year":"2011","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0590","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1006\/bbrc.1994.2817","article-title":"Purification to homogeneity of mitochondrial acyl coa:glycine n-acyltransferase from human liver","volume":"205","author":"Mawal","year":"1994","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0595","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbapap.2005.08.004","article-title":"A preliminary account of the properties of recombinant human Glyoxylate reductase (GRHPR), LDHA and LDHB with glyoxylate, and their potential roles in its metabolism","volume":"1753","author":"Mdluli","year":"2005","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0600","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0277-5379(86)90368-8","article-title":"Prediction of ifosfamide\/mesna associated encephalopathy","volume":"22","author":"Meanwell","year":"1986","journal-title":"European Journal of Cancer & Clinical Oncology"},{"issue":"8425","key":"10.1016\/j.pharmthera.2012.05.003_bb0605","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0140-6736(85)91432-1","article-title":"Encephalopathy associated with ifosfamide\/mesna therapy","volume":"i","author":"Meanwell","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0610","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/01.RES.6.4.482","article-title":"Effect of nicotinic acid on the incorporation of radiocarbon into cholesterol","volume":"6","author":"Merrill","year":"1958","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0615","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/138955706776361385","article-title":"Ifosfamide. Metabolic studies, new therapeutic approaches and new analogs","volume":"6","author":"Misiura","year":"2006","journal-title":"Mini Reviews in Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0620","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0022-3565(25)20702-9","article-title":"Metabolism of the glutathione-acrolein adduct, S-(2-aldehydo-ethyl)glutathione, by rat liver alcohol and aldehyde dehydrogenase","volume":"251","author":"Mitchell","year":"1989","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0625","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00432-005-0015-2","article-title":"Dynamic analysis of metabolic effects of chloroacetaldehyde and cytochalasin B on tumor cells using bioelectronic sensor chips","volume":"131","author":"Motrescu","year":"2005","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0630","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1176\/appi.ajp.162.9.1738","article-title":"Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type","volume":"162","author":"Neeman","year":"2005","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0635","first-page":"127","article-title":"Fixed drug eruptions; a report of two cases, one caused by niacin, the other by cocaine","volume":"82","author":"Nelson","year":"1955","journal-title":"California Medicine"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0640","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1158\/0008-5472.CAN-06-1043","article-title":"Ifosfamide-induced nephrotoxicity: mechanism and prevention","volume":"66","author":"Nissim","year":"2006","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0645","first-page":"437","article-title":"Studies on the metabolism of isophosphamide (NSC-109724) in man","volume":"60","author":"Norpoth","year":"1976","journal-title":"Cancer Treatment Reports"},{"issue":"8442","key":"10.1016\/j.pharmthera.2012.05.003_bb0650","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0140-6736(85)91829-X","article-title":"Ifosfamide, mesna, and encephalopathy","volume":"i","author":"Osborne","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0655","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/med.20177","article-title":"Cellular and molecular actions of Methylene Blue in the nervous system","volume":"31","author":"Oz","year":"2011","journal-title":"Medicinal Research Reviews"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0660","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000457499","article-title":"Conjugation of benzoic acid with glycine in the human fetal and adult liver and kidney","volume":"17","author":"Pacifici","year":"1991","journal-title":"Developmental Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0665","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00424-003-1099-7","article-title":"The mitochondrial transporter family (SLC25): physiological and pathological implications","volume":"447","author":"Palmieri","year":"2004","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0670","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/096032719000900606","article-title":"Depletion of plasma glycine and effect of glycine by mouth on salicylate metabolism during aspirin overdose","volume":"9","author":"Patel","year":"1990","journal-title":"Human & Experimental Toxicology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0675","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jn\/13.2.123","article-title":"A comparison of the glycine contents of the proteins of normal and chondrodystrophic chick embryos at different stages of development","volume":"13","author":"Patton","year":"1937","journal-title":"The Journal of Nutrition"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0680","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3810\/pgm.2009.07.2041","article-title":"Salicylate intoxication: a clinical review","volume":"121","author":"Pearlman","year":"2009","journal-title":"Postgraduate Medicine"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0685","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/hep.21528","article-title":"Human and rat bile acid-CoA:amino acid N-acyltransferase are liver-specific peroxisomal enzymes: implications for intracellular bile salt transport","volume":"45","author":"Pellicoro","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0690","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/neu.480070205","article-title":"Movement of glycine across the blood-brain barrier of the rabbit","volume":"7","author":"Pollay","year":"1976","journal-title":"Journal of Neurobiology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0695","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00018-007-6558-4","article-title":"Physiological functions of D-amino acid oxidases: from yeast to humans","volume":"64","author":"Pollegioni","year":"2007","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0700","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0090-9556(25)06528-6","article-title":"Benzoic acid glycine conjugation in the isolated perfused rat kidney","volume":"23","author":"Poon","year":"1995","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0705","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0005-2728(00)00172-9","article-title":"Mammalian mitochondrial inner membrane cationic and neutral amino acid carriers","volume":"1459","author":"Porter","year":"2000","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0710","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0021-9258(18)76545-9","article-title":"The conjugation of benzoic acid in man","volume":"92","author":"Quick","year":"1931","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0715","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archinte.1936.00170070069006","article-title":"Clinical value of the test for hippuric acid in cases of disease of the liver","volume":"57","author":"Quick","year":"1936","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0720","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0090-9556(24)14896-9","article-title":"Inhibition of human aldehyde dehydrogenase 1 by the 4-hydroxycyclophosphamide degradation product acrolein","volume":"27","author":"Ren","year":"1999","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0725","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pediatrneurol.2009.05.005","article-title":"Early myoclonic encephalopathy and nonketotic hyperglycinemia","volume":"41","author":"Rossi","year":"2009","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0730","doi-asserted-by":"crossref","first-page":"9755","DOI":"10.1523\/JNEUROSCI.0509-08.2008","article-title":"The glycine transporter GlyT2 controls the dynamics of synaptic vesicle refilling in inhibitory spinal cord neurons","volume":"28","author":"Rousseau","year":"2008","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0740","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/212292a0","article-title":"Free amino acids of human foetal and adult liver","volume":"212","author":"Ryan","year":"1966","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0735","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/cncr.23478","article-title":"Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas","volume":"112","author":"Ryan","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0745","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00415-011-5990-4","article-title":"Ifosfamide associated myoclonus-encephalopathy syndrome","volume":"258","author":"Savica","year":"2011","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0750","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0021-9258(18)65643-1","article-title":"Glycine N-acylase: purification and properties","volume":"208","author":"Schachter","year":"1954","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0755","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/182534a0","article-title":"Effect of nicotinic acid on the cholesterol contents of rat-livers","volume":"182","author":"Sch\u00f6n","year":"1958","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0760","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0021-9258(19)52819-8","article-title":"The utilization of glycine for the synthesis of a porphyrin","volume":"159","author":"Shemin","year":"1945","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0765","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1570-9639(03)00095-5","article-title":"5-Aminolevulinic acid synthase: mechanism, mutations and medicine","volume":"1647","author":"Shoolingin-Jordan","year":"2003","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0770","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S0022-2275(20)32022-8","article-title":"Subcellular organization of bile acid amidation in human liver: a key issue in regulating the biosynthesis of bile salts","volume":"41","author":"Solaas","year":"2000","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0775","first-page":"S287","article-title":"2-Chloroacetaldehyde-induced cerebral glutathione depletion and neurotoxicity","volume":"27","author":"Sood","year":"1996","journal-title":"The British Journal of Cancer. Supplement"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0780","first-page":"42","article-title":"Distribution of messenger RNAs for aldehyde dehydrogenase 1, aldehyde dehydrogenase 2, and aldehyde dehydrogenase 5 in human tissues","volume":"44","author":"Stewart","year":"1996","journal-title":"Journal of Investigative Medicine"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0785","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.pediatrneurol.2010.04.018","article-title":"Nonketotic hyperglycinemia: proposal of a diagnostic and treatment strategy","volume":"43","author":"Suzuki","year":"2010","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0790","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00776-009-1431-y","article-title":"Ifosfamide encephalopathy associated with chemotherapy for musculoskeletal sarcomas: incidence, severity, and risk factors","volume":"15","author":"Tajino","year":"2010","journal-title":"Journal of Orthopaedic Science"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0795","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/BF00964352","article-title":"Elevation of cerebral levels of nonessential amino acids in vivo by administration of large doses","volume":"6","author":"Toth","year":"1981","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0800","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1432-1033.1982.tb06709.x","article-title":"A comprehensive approach to the study of collagen primary structure based on high-performance liquid chromatography","volume":"125","author":"van der Rest","year":"1982","journal-title":"European Journal of Biochemistry"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0805","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/(SICI)1099-0461(2000)14:2<102::AID-JBT6>3.0.CO;2-H","article-title":"The utilization of alanine, glutamic acid, and serine as amino acid substrates for glycine N-acyltransferase","volume":"14","author":"van der Westhuizen","year":"2000","journal-title":"Journal of Biochemical and Molecular Toxicology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0810","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jchromb.2006.08.052","article-title":"Development of an at-line method for the identification of angiotensin-I inhibiting peptides in protein hydrolysates","volume":"846","author":"van Platerink","year":"2007","journal-title":"Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0815","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1080\/02652030902858939","article-title":"Estimate of intake of benzoic acid in the Belgian adult population","volume":"26","author":"Vandevijvere","year":"2009","journal-title":"Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0820","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0304-4165(99)00088-4","article-title":"Characterization of the CoA ligases of human liver mitochondria catalyzing the activation of short- and medium-chain fatty acids and xenobiotic carboxylic acids","volume":"1428","author":"Vessey","year":"1999","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0825","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbt.10056","article-title":"Isolation, sequencing, and expression of a cDNA for the HXM-A form of xenobiotic\/medium-chain fatty acid:CoA ligase from human liver mitochondria","volume":"17","author":"Vessey","year":"2003","journal-title":"Journal of Biochemical and Molecular Toxicology"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0830","first-page":"193","article-title":"Thiodiglycolic acid is excreted by humans receiving ifosfamide and inhibits mitochondrial function in rats","volume":"26","author":"Visarius","year":"1998","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0835","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1177\/106002809202601116","article-title":"Contribution of the human kidney to the metabolic clearance of drugs","volume":"26","author":"Vree","year":"1992","journal-title":"The Annals of Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0840","article-title":"Characterization of [(11)C]RO5013853, a novel PET tracer for the glycine transporter type 1 (GlyT1) in humans","author":"Wong","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0845","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1479-8425.2007.00262.x","article-title":"Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes","volume":"5","author":"Yamadera","year":"2007","journal-title":"Sleep and Biological Rhythms"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0850","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0041-1345(03)00482-2","article-title":"A simple new formula to assess liver weight","volume":"35","author":"Yoshizumi","year":"2003","journal-title":"Transplantation Proceedings"},{"key":"10.1016\/j.pharmthera.2012.05.003_bb0855","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0300-483X(80)90014-1","article-title":"Decrease of reduced glutathione in isolated rat hepatocytes caused by acrolein, acrylonitrile, and the thermal degradation products of styrene copolymers","volume":"17","author":"Zitting","year":"1980","journal-title":"Toxicology"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725812000836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725812000836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T11:22:58Z","timestamp":1743592978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725812000836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":171,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0163725812000836"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2012.05.003","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}